Atlas Trials

Appatinib Combined With S-1 in the Treatment of Small Cell Lung Cancer

Clinical trial NCT04128800 · UNKNOWN

Trial details

NCT number
NCT04128800
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Small Cell Lung Cancer
Start date
2019-10-01
Primary completion
2020-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.